干性年龄相关性黄斑变性-口服补充剂,哪种组合,何时?

T. Lekha
{"title":"干性年龄相关性黄斑变性-口服补充剂,哪种组合,何时?","authors":"T. Lekha","doi":"10.7869/DJO.348","DOIUrl":null,"url":null,"abstract":"Age related macular degeneration (AMD), a leading cause of visual loss in the elderly, is emerging as an important public health problem due to the increase in the ageing population. Dry AMD which is the more prevalent form has no effective treatment and so efforts are directed to slow down or prevent progression of retinal changes by optimizing the risk, factors for AMD. Oxidative stress in the retina has been identified as an important predisposing factor which can be most efficiently modified by nutritional supplementation. Two large randomized controlled trials namely AREDS (Age related eye disease study) 1 and 2 provided high quality evidence to support the use of vitamins and micronutrients in preventing the progression of disease, especially in those with intermediate or advanced AMD. Supplementation with oral antioxidants soon became the standard of care for dry AMD, both due to its perceived universal benefit and its cost effectiveness. Though a wide range of antioxidants are available in the market, hardly any of them contain ingredients recommended by AREDS in the correct dosage. It is therefore important that ophthalmologists should be equipped with proper information regarding these products and advise the patients appropriately after considering their individual needs. A comprehensive list of antioxidants available in our country is included in this article which can be used as a reference to guide the patients. Physicians should be familiar with AREDS recommendations and should select patients appropriately. Patient education to improve compliance and counseling regarding life style modifications are also important in controlling this public health problem. interplay","PeriodicalId":23047,"journal":{"name":"The Official Scientific Journal of Delhi Ophthalmological Society","volume":"170 1","pages":"11-15"},"PeriodicalIF":0.0000,"publicationDate":"2018-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dry Age Related Macular Degeneration – Oral Supplements, Which Combination and When ?\",\"authors\":\"T. Lekha\",\"doi\":\"10.7869/DJO.348\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Age related macular degeneration (AMD), a leading cause of visual loss in the elderly, is emerging as an important public health problem due to the increase in the ageing population. Dry AMD which is the more prevalent form has no effective treatment and so efforts are directed to slow down or prevent progression of retinal changes by optimizing the risk, factors for AMD. Oxidative stress in the retina has been identified as an important predisposing factor which can be most efficiently modified by nutritional supplementation. Two large randomized controlled trials namely AREDS (Age related eye disease study) 1 and 2 provided high quality evidence to support the use of vitamins and micronutrients in preventing the progression of disease, especially in those with intermediate or advanced AMD. Supplementation with oral antioxidants soon became the standard of care for dry AMD, both due to its perceived universal benefit and its cost effectiveness. Though a wide range of antioxidants are available in the market, hardly any of them contain ingredients recommended by AREDS in the correct dosage. It is therefore important that ophthalmologists should be equipped with proper information regarding these products and advise the patients appropriately after considering their individual needs. A comprehensive list of antioxidants available in our country is included in this article which can be used as a reference to guide the patients. Physicians should be familiar with AREDS recommendations and should select patients appropriately. Patient education to improve compliance and counseling regarding life style modifications are also important in controlling this public health problem. interplay\",\"PeriodicalId\":23047,\"journal\":{\"name\":\"The Official Scientific Journal of Delhi Ophthalmological Society\",\"volume\":\"170 1\",\"pages\":\"11-15\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Official Scientific Journal of Delhi Ophthalmological Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7869/DJO.348\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Official Scientific Journal of Delhi Ophthalmological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7869/DJO.348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

年龄相关性黄斑变性(AMD)是老年人视力丧失的主要原因,由于人口老龄化的增加,它正在成为一个重要的公共卫生问题。干性黄斑变性是更普遍的形式,没有有效的治疗方法,因此努力通过优化黄斑变性的风险因素来减缓或防止视网膜变化的进展。氧化应激在视网膜已被确定为一个重要的易感因素,可以最有效地通过营养补充修改。两项大型随机对照试验AREDS(年龄相关性眼病研究)1和2提供了高质量的证据,支持使用维生素和微量营养素预防疾病进展,特别是在中晚期AMD患者中。补充口服抗氧化剂很快成为干性AMD的标准护理,由于其普遍的好处和成本效益。虽然市场上有各种各样的抗氧化剂,但几乎没有一种含有AREDS推荐的正确剂量的成分。因此,重要的是,眼科医生应该配备有关这些产品的适当信息,并在考虑患者的个人需求后适当地建议患者。本文列出了我国现有抗氧化剂的综合清单,可作为指导患者的参考。医生应熟悉AREDS的建议,并应适当地选择患者。对患者进行教育以提高依从性并就改变生活方式进行咨询,对于控制这一公共卫生问题也很重要。相互作用
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dry Age Related Macular Degeneration – Oral Supplements, Which Combination and When ?
Age related macular degeneration (AMD), a leading cause of visual loss in the elderly, is emerging as an important public health problem due to the increase in the ageing population. Dry AMD which is the more prevalent form has no effective treatment and so efforts are directed to slow down or prevent progression of retinal changes by optimizing the risk, factors for AMD. Oxidative stress in the retina has been identified as an important predisposing factor which can be most efficiently modified by nutritional supplementation. Two large randomized controlled trials namely AREDS (Age related eye disease study) 1 and 2 provided high quality evidence to support the use of vitamins and micronutrients in preventing the progression of disease, especially in those with intermediate or advanced AMD. Supplementation with oral antioxidants soon became the standard of care for dry AMD, both due to its perceived universal benefit and its cost effectiveness. Though a wide range of antioxidants are available in the market, hardly any of them contain ingredients recommended by AREDS in the correct dosage. It is therefore important that ophthalmologists should be equipped with proper information regarding these products and advise the patients appropriately after considering their individual needs. A comprehensive list of antioxidants available in our country is included in this article which can be used as a reference to guide the patients. Physicians should be familiar with AREDS recommendations and should select patients appropriately. Patient education to improve compliance and counseling regarding life style modifications are also important in controlling this public health problem. interplay
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信